Skip to main content
PRO 7 min read

New Guidelines on Metabolic Syndrome

New Guidelines on Metabolic Syndrome
1 photo
519
Smart Voice AI
0:00
0:00
Listen to the article content live
Table of Contents 10
PRO Content PRO

This article is professional premium content (PRO) provided in its entirety.

The metabolic syndrome (MTS), comprising a collection of factors whose concurrent occurrence elevates the risk of developing cardiovascular disorders, is being accorded increasing importance in society. It potentially impacts every third adult, and an escalating trend is noted. For numerous years, a debate has been raging regarding the diagnostic and therapeutic criteria for the metabolic syndrome. In 2022, a new proposal was unveiled by specialists hailing from Poland.
01 / 10

The evolution and definitions of metabolic syndrome: From ancient observations to contemporary diagnostic criteria

Examining the historical background of metabolic syndrome provides critical insight into its complexity as well as the evolution of its terminology and diagnostic frameworks. The earliest documented observations linking excessive food consumption, obesity, and cardiovascular disturbances date back to ancient Egypt, where accounts described sudden cardiac arrest in individuals with elevated body weight. Systematic descriptions of cases resembling the modern understanding of metabolic syndrome likely emerged in the 17th and 18th centuries, but it was not until the 20th century that scientific research began to systematically explore the relationships between lifestyle factors and the development of metabolic disorders—including insulin resistance, dyslipidemia, and hypertension. Earlier attempts to classify this cluster of conditions employed terms such as "triad syndrome" or "syndrome of affluence," reflecting contemporaneous perceptions of socioeconomic causes. The formal designation "metabolic syndrome" was proposed in 1981 by German researchers, with its initial definition encompassing the co-occurrence of obesity, type 2 diabetes, hyperlipidemia (elevated total cholesterol and triglyceride levels), hypertension, and gout—conditions that significantly increase the risk of coronary artery disease and renal calculi. Over subsequent decades, various medical organizations, including the World Health Organization (WHO), the International Diabetes Federation (IDF), and the American Heart Association (AHA), developed distinct diagnostic criteria that varied in both selected parameters and threshold values. The most recent consensus, published in 2009 by the IDF in collaboration with the AHA and the National Heart, Lung, and Blood Institute (NHLBI), establishes that metabolic syndrome may be diagnosed when at least three of five criteria are met: (1) abdominal obesity (waist circumference ≥ 94 cm in men and ≥ 80 cm in women for European populations), (2) hypertriglyceridemia (≥ 150 mg/dL or triglyceride-lowering therapy), (3) low HDL cholesterol (< 40 mg/dL in men and < 50 mg/dL in women or HDL-raising treatment), (4) elevated blood pressure (≥ 130/85 mmHg or antihypertensive therapy), and (5) elevated fasting glucose (≥ 100 mg/dL or glucose-lowering treatment).
02 / 10

Updated diagnostic guidelines for metabolic syndrome: a 2022 consensus perspective

In light of the substantial advancements in medical knowledge observed over recent years, a consortium of Polish scientific societies and research institutions formally introduced revised diagnostic criteria for metabolic syndrome in 2022. The foundational, non-negotiable prerequisite for diagnosis remains the confirmation of obesity—defined either as a body mass index (BMI) of 30 kg/m² or greater, or a waist circumference measuring at least 88 centimeters in females and 102 centimeters in males. Additionally, the presence of at least two of the following three abnormalities is mandatory for diagnostic confirmation: 1. Impaired glucose metabolism—evidenced by fasting plasma glucose concentrations ≥ 100 mg/dL, postprandial hyperglycemia (≥ 140 mg/dL at 120 minutes during an oral glucose tolerance test), elevated glycated hemoglobin levels (≥ 5.7%), or the requirement for glucose-lowering pharmacotherapy; 2. Arterial hypertension—diagnosed when systolic and/or diastolic blood pressure values reach ≥ 130/85 mmHg in clinical settings or ≥ 130/80 mmHg in home measurements, or when antihypertensive treatment is administered; 3. Dyslipidemia marked by elevated non-high-density lipoprotein cholesterol (≥ 130 mg/dL) or the use of lipid-modifying agents. Furthermore, building upon research conducted by Professor Piotr Dobrowolski’s team (2022), experts have delineated a spectrum of frequently co-occurring clinical features that, while not essential for diagnosis, may indicate advanced pathological progression. These include: renal dysfunction of varying severity, non-alcoholic fatty liver disease, obstructive sleep apnea, heart failure with preserved ejection fraction, polycystic ovary syndrome (PCOS), low-grade chronic inflammation, sympathetic nervous system overactivation, and hyperuricemia—an elevated serum uric acid concentration.
03 / 10

Comparative analysis of diagnostic guidelines for metabolic syndrome across expert consensus sources

This document provides a structured comparison and critical evaluation of the diagnostic criteria for metabolic syndrome as established by leading international medical societies, alongside an innovative diagnostic proposal developed by a team of Polish researchers—including the 2014 publications by M. Kramkowska and K. Czyżewska, as well as the subsequent 2022 study by P. Dobrowolski and colleagues, which introduces significant modifications relative to prior consensus guidelines.
04 / 10

World Health Organization – 1998 Diagnostic Criteria

Disorders of carbohydrate metabolism encompassing: impaired glucose tolerance, abnormal fasting glycemia, or established type 2 diabetes mellitus. Additionally, at least two of the following coexisting conditions must be present: • excessive accumulation of visceral adipose tissue (central or abdominal obesity), • dysregulated lipid profile (elevated circulating triglyceride concentrations coupled with reduced high-density lipoprotein cholesterol levels), • hypertensive blood pressure readings, • urinary excretion of microalbumin (microalbuminuria).
05 / 10

Regulation (EU) 2024/XXX shall apply from the date twenty days after its publication in the *Official Journal of the European Union*

The metabolic syndrome is identified under the 1999 EGIR criteria by the presence of insulin resistance (elevated fasting insulin levels) alongside at least two of the following clinical features: • abdominal (central) obesity, • lipid metabolism disorders (dyslipidemia), • elevated arterial blood pressure or ongoing antihypertensive treatment, • impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), provided that overt type 2 diabetes mellitus has been excluded from the diagnosis.
06 / 10

AACE 2003 Guidelines for the Classification of Metabolic Dysregulation Conditions

A clinical state defined by impaired glucose tolerance or abnormal fasting plasma glucose levels in the absence of confirmed type 2 diabetes mellitus. Concomitantly, at least one of the following risk factors must be present: • excess body weight (BMI ≥25 kg/m²) or obesity (BMI ≥30 kg/m²), • lipid metabolism disorder (dyslipidemia) characterized by elevated triglyceride concentrations or reduced high-density lipoprotein (HDL) cholesterol, • elevated blood pressure readings (≥130/85 mmHg), • first-degree family history of type 2 diabetes, • diagnosed polycystic ovary syndrome (PCOS), • physical inactivity (sedentary lifestyle), • age exceeding 40–45 years (with population-specific variations).
07 / 10

Diagnostic Criteria for Metabolic Syndrome per the International Diabetes Federation (I.D.F., 2005)

Metabolic syndrome is identified when central (abdominal) obesity—defined by population- and gender-specific waist circumference thresholds—coexists with at least two of the following abnormalities: elevated triglyceride concentrations (≥ 150 mg/dL) or pharmacologic treatment for this condition, reduced high-density lipoprotein (HDL) cholesterol levels (< 40 mg/dL in men, < 50 mg/dL in women) or therapy aimed at increasing HDL, elevated blood pressure (≥ 130/85 mmHg) or antihypertensive medication use, and elevated fasting plasma glucose (≥ 100 mg/dL) or previously diagnosed type 2 diabetes mellitus.
08 / 10

Allocation designated for the following purposes in accordance with established regulatory frameworks:

The diagnostic criteria for metabolic syndrome necessitate the presence of at least three of the following abnormalities—or their ongoing pharmacological management: • abdominal (visceral) obesity characterized by excessive central fat deposition, • elevated circulating triglyceride concentrations (hypertriglyceridemia) or active lipid-lowering treatment, • reduced high-density lipoprotein (HDL) cholesterol levels (often referred to as "beneficial cholesterol") or therapeutic intervention, • sustained arterial hypertension (elevated blood pressure) or antihypertensive medication use, • impaired fasting glucose (hyperglycemia) or glucose-modulating therapy.
09 / 10

This appropriation is intended to cover the expenditure incurred in connection with the implementation of the programme, in particular the financial support provided for in Article 107 (3) (c) of the Treaty on the Functioning of the European Union (TFEU)

According to unified consensus criteria, a diagnosis of metabolic syndrome requires the presence of abdominal obesity along with at least two of the following clinical components: – Impaired fasting glucose (≥ 100 mg/dL), impaired glucose tolerance, elevated glycated hemoglobin (HbA1c), or pharmacological treatment for diabetes; – Elevated blood pressure (systolic ≥ 130 mmHg and/or diastolic ≥ 85 mmHg) or antihypertensive therapy; – Elevated serum triglycerides (≥ 150 mg/dL) or specific lipid-lowering treatment; – Reduced HDL cholesterol (< 40 mg/dL in men, < 50 mg/dL in women) or elevated non-HDL cholesterol. Most major cardiovascular and endocrinology associations converge on these core risk parameters. A notable update in recent guidelines is the formal incorporation of glycated hemoglobin (HbA1c) as a diagnostic indicator of carbohydrate dysregulation, reflecting glycemic control over preceding months. Furthermore, non-HDL cholesterol is emphasized as a superior marker of total atherogenic lipoprotein burden. Importantly, receiving pharmacotherapy for any component confirms its presence, as ongoing medical management does not eliminate baseline cardiovascular risk.
10 / 10

Therapeutic management guidelines and lifestyle modifications in metabolic syndrome

The comprehensive management of metabolic syndrome (MetS) necessitates multidimensional lifestyle modifications, encompassing evidence-based nutritional strategies, structured physical activity regimens, optimization of sleep architecture, and the cessation of harmful substances such as tobacco and alcohol. Below are the detailed dietary guidelines for individuals diagnosed with MetS, accompanied by clinically validated outcomes stemming from their implementation (derived from Dobrowolski et al., 2022). It is critical to emphasize, however, that these recommendations must be individually tailored to account for the heterogeneous health statuses, physiological capacities, and psychological profiles of patients.
Meal Plan

Want to apply these guidelines in your daily diet?

Our smart diet generator creates a tailored meal plan in 3 minutes based on the recommendations in this article.

Dobrowolski P. et al., Zespół metaboliczny — nowa definicja i postępowanie w praktyce, „Nadciśnienie Tętnicze w Praktyce” 2022, 8(2), 47–72.
Kramkowska M., Czyżewska K., Zespół metaboliczny — historia, definicje, kontrowersje, „Forum Zaburzeń Metabolicznych” 2014, 5 (1), 6–15.
Saklayen M.G., The Global Epidemic of the Metabolic Syndrome, „Current Hypertension Reports” 2018, 20(2), 12.
Scientifically reviewed by a clinical dietitian • 25.09.2026

Dobrowolski P. et al., Zespół metaboliczny — nowa definicja i postępowanie w praktyce, „Nadciśnienie Tętnicze w Praktyce” 2022, 8(2), 47–72. Kramkowska M., Czyżewska K., Zespół metaboliczny — historia, definicje, kontrowersje, „Forum Zaburzeń Metabolicznych” 2014, 5 (1), 6–15. Saklayen M.G., The Global Epidemic of the Metabolic Syndrome, „Current Hypertension Reports” 2018, 20(2), 12.

Diets Premium Expert

Diets Premium team expert. Specializes in nutrition plans, strength sports, and training plans.

USDA FoodData Central EFSA PubMed Clinical Guidelines
Loading
Recommended articles in this category

Related Articles

Discover similar publications and expert insights.

Metabolic Syndrome: Symptoms, Causes, Consequences, Treatment and Suitable Diet
Metabolic

Metabolic Syndrome: Symptoms, Causes, Consequences, Treatment and Suitable Diet

⏱ 5 min czytania
#Metabolic #Metabolic Syndrome
What is the metabolic syndrome?
Health

What is the metabolic syndrome?

⏱ 3 min czytania 📚 Health
#Metabolic Syndrome #Diabetes
Metabolic Syndrome – Concept, Diagnosis, and Dietary Therapy
Metabolic Syndrome

Metabolic Syndrome – Concept, Diagnosis, and Dietary Therapy

⏱ 6 min czytania
#Metabolic Syndrome #Type 2 Diabetes
Triglycerides - too high, too low, the norm... How to decrease triglyceride levels?
Cardiovascular Health

Triglycerides - too high, too low, the norm... How to decrease triglyceride levels?

⏱ 6 min czytania 📚 Cardiovascular Health
#Type 2 Diabetes #Metabolic
Is this truly an effective diet for individuals with metabolic disorders - which foods should be included and which should be avoided?
Health Conditions

Is this truly an effective diet for individuals with metabolic disorders - which foods should be included and which should be avoided?

⏱ 5 min czytania 📚 Health Conditions
#Metabolic Disorders #Metabolic Syndrome
Diabetes, obesity, and hypertension as significant health challenges for today's youth
Metabolic Disorders

Diabetes, obesity, and hypertension as significant health challenges for today's youth

⏱ 10 min czytania
#Metabolic Disorders #Metabolic Syndrome
Metabolic disorder - Causes and prevention
Weight Loss And Exercise

Metabolic disorder - Causes and prevention

⏱ 5 min czytania
#Weight Loss And Exercise #Weight Loss And Diet
The metabolic disorder known as Gilbert's Syndrome – symptoms, causative factors, diagnostic methods, and pregnancy
Pregnancy & Motherhood

The metabolic disorder known as Gilbert's Syndrome – symptoms, causative factors, diagnostic methods, and pregnancy

⏱ 4 min czytania 📚 Pregnancy & Motherhood
#Metabolic #Liver
4 Products That Will Rev Up Your Metabolism
Metabolism

4 Products That Will Rev Up Your Metabolism

⏱ 4 min czytania 📚 Metabolism
#Metabolism #Low-calorie Diet
Elimination of Toxins from the Body Using Vitamin E
Detoxification

Elimination of Toxins from the Body Using Vitamin E

⏱ 2 min czytania
#Detoxification #Vitamin A Benefits
Diabetes and Physical Activity
Sedentary Health

Diabetes and Physical Activity

⏱ 5 min czytania 📚 Sedentary Health
#Physical Activity #Diabetes
MODY-Type Diabetes - A Rare Yet Significant Health Issue
Weight Management

MODY-Type Diabetes - A Rare Yet Significant Health Issue

⏱ 7 min czytania 📚 Weight Management
#Obesity #Type 2 Diabetes
What is the underlying factor for rapid weight loss?
Weight Loss

What is the underlying factor for rapid weight loss?

⏱ 4 min czytania 📚 Weight Loss
#Weight Loss #Calorie Deficit
"Skinny fat" - result of incorrect weight reduction
Weight Loss

"Skinny fat" - result of incorrect weight reduction

⏱ 5 min czytania
#Weight Loss #Metabolic
Dietary Magnesium: Key Food Sources, Thermal Processing Losses, and Bioavailability Factors
Nutritional Science

Dietary Magnesium: Key Food Sources, Thermal Processing Losses, and Bioavailability Factors

⏱ 4 min czytania 📚 Nutritional Science
#Food Processing #Magnesium
Role of Thioctic Acid in Hyperglycemic Complications: Molecular Mechanisms, Dosage, and Clinical Efficacy
Nutritional Science

Role of Thioctic Acid in Hyperglycemic Complications: Molecular Mechanisms, Dosage, and Clinical Efficacy

⏱ 3 min czytania 📚 Nutritional Science
#Bioactive Compounds #Antioxidant
Green Tea (Camellia sinensis) – Health Benefits, Catechins (EGCG), and Physiological Impact
Functional Foods

Green Tea (Camellia sinensis) – Health Benefits, Catechins (EGCG), and Physiological Impact

⏱ 3 min czytania 📚 Functional Foods
#Coronary Artery Disease #Camellia Sinensis
Optimal Dietary Strategies for Lactose Intolerance – Minimizing Gastrointestinal Discomfort
Nutritional Science

Optimal Dietary Strategies for Lactose Intolerance – Minimizing Gastrointestinal Discomfort

⏱ 8 min czytania 📚 Nutritional Science
#Dietary Recommendations #Lactose Intolerance
Contemporary vs. Traditional Antidiabetic Pharmacotherapy: Metformin, SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Sulfonylureas in Paradigm Shifts
Nutritional Science

Contemporary vs. Traditional Antidiabetic Pharmacotherapy: Metformin, SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Sulfonylureas in Paradigm Shifts

⏱ 6 min czytania 📚 Nutritional Science
#Antidiabetic #Sulfonylurea
Discover how the synergistic blend of natural honey and cinnamon may accelerate healthy and sustainable weight reduction!
Weight Management

Discover how the synergistic blend of natural honey and cinnamon may accelerate healthy and sustainable weight reduction!

⏱ 1 min czytania 📚 Weight Management
#Weight Management #Cinnamon-flavored
Mycotoxins - Classification, pathways of exposure and symptoms and treatment of poisoning
Food Safety

Mycotoxins - Classification, pathways of exposure and symptoms and treatment of poisoning

⏱ 6 min czytania 📚 Food Safety
#Transportation #Metabolic
Could it genuinely be pure honey, unrefined cane sugar, or simply fructose? Which sweetened products may individuals diagnosed with diabetes safely incorporate into their diet?
Diabetes (Low Gi)

Could it genuinely be pure honey, unrefined cane sugar, or simply fructose? Which sweetened products may individuals diagnosed with diabetes safely incorporate into their diet?

⏱ 3 min czytania 📚 Diabetes (Low GI)
#Diabetes Management #Type 2 Diabetes
Nutrition after 40 - dietary strategy, recipes. which weight management approach is most effective after turning 40?
Balanced Nutrition

Nutrition after 40 - dietary strategy, recipes. which weight management approach is most effective after turning 40?

⏱ 4 min czytania
#Balanced Nutrition #Weight Management
Plants for Kidneys... Dissolving Kidney Stones Using Plants
Natural Remedies

Plants for Kidneys... Dissolving Kidney Stones Using Plants

⏱ 5 min czytania
#Natural Remedies #Diuretic
Diatomaceous earth for weight loss: the side effects of using diatomaceous earth
Obesity

Diatomaceous earth for weight loss: the side effects of using diatomaceous earth

⏱ 3 min czytania
#Obesity #Metabolic
Genetically Determined Fructose Intolerance: Symptoms, Diagnosis, and Dietary Recommendations
Dietary Recommendations

Genetically Determined Fructose Intolerance: Symptoms, Diagnosis, and Dietary Recommendations

⏱ 5 min czytania
#Dietary Recommendations #Sweet
Assessment of the Effectiveness of Obesity Treatment Methods – Historical Review
Obesity

Assessment of the Effectiveness of Obesity Treatment Methods – Historical Review

⏱ 5 min czytania
#Obesity #Metabolic
How to Effectively Boost Metabolism
Weight Loss

How to Effectively Boost Metabolism

⏱ 4 min czytania
#Weight Loss #Metabolism
Potassium – An Indispensable Constituent of Our Body!
Electrolyte

Potassium – An Indispensable Constituent of Our Body!

⏱ 3 min czytania
#Electrolyte #Metabolic
What Are the Symptoms of Diabetes? Skin Symptoms of Diabetes
Carbohydrate Metabolism

What Are the Symptoms of Diabetes? Skin Symptoms of Diabetes

⏱ 4 min czytania
#Carbohydrate Metabolism #Diabetes Type 2
For Trainees

Latest Diets

Discover other diet plans with similar goals and nutrients.

Share